Cormorant Asset Management as of Dec. 31, 2022
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 72 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Prometheus Biosciences | 15.4 | $230M | 2.1M | 110.00 | |
Apellis Pharmaceuticals (APLS) | 5.5 | $82M | 1.6M | 51.71 | |
Arcellx Common Stock (ACLX) | 4.3 | $64M | 2.1M | 30.98 | |
Moonlake Immunotherapeutics Class A Ord (MLTX) | 4.3 | $64M | 6.1M | 10.50 | |
Avidity Biosciences Ord (RNA) | 4.1 | $61M | 2.8M | 22.19 | |
Aerovate Therapeutics (AVTE) | 3.8 | $57M | 2.0M | 29.30 | |
Design Therapeutics (DSGN) | 3.5 | $53M | 5.2M | 10.26 | |
Altimmune Com New (ALT) | 3.3 | $49M | 3.0M | 16.45 | |
Erasca (ERAS) | 3.1 | $47M | 11M | 4.31 | |
Revolution Medicines (RVMD) | 3.0 | $45M | 1.9M | 23.82 | |
Ventyx Biosciences (VTYX) | 2.4 | $35M | 1.1M | 32.79 | |
89bio (ETNB) | 2.2 | $33M | 2.6M | 12.73 | |
Miragen Therapeutics (VRDN) | 2.2 | $32M | 1.1M | 29.21 | |
Bioatla (BCAB) | 2.0 | $30M | 3.7M | 8.25 | |
Tango Therapeutics (TNGX) | 2.0 | $30M | 4.1M | 7.25 | |
Biomea Fusion (BMEA) | 1.8 | $27M | 3.2M | 8.43 | |
Edgewise Therapeutics (EWTX) | 1.8 | $26M | 2.9M | 8.94 | |
Sarepta Therapeutics (SRPT) | 1.7 | $26M | 200k | 129.58 | |
Tarsus Pharmaceuticals (TARS) | 1.7 | $26M | 1.7M | 14.66 | |
Axsome Therapeutics (AXSM) | 1.7 | $25M | 325k | 77.13 | |
Astria Therapeutics (ATXS) | 1.6 | $25M | 1.7M | 14.89 | |
Rain Therapeutics | 1.6 | $24M | 3.0M | 8.00 | |
Monte Rosa Therapeutics (GLUE) | 1.5 | $22M | 2.9M | 7.61 | |
Vectivbio Hldg Ord Shs | 1.5 | $22M | 2.5M | 8.67 | |
Karuna Therapeutics Ord | 1.4 | $22M | 110k | 196.50 | |
Amylyx Pharmaceuticals (AMLX) | 1.4 | $20M | 550k | 36.95 | |
Axonics Modulation Technolog (AXNX) | 1.3 | $20M | 322k | 62.53 | |
Cabaletta Bio (CABA) | 1.2 | $18M | 2.0M | 9.25 | |
Mirati Therapeutics | 1.2 | $18M | 400k | 45.31 | |
Rocket Pharmaceuticals (RCKT) | 1.1 | $17M | 869k | 19.57 | |
Vaxcyte (PCVX) | 1.0 | $16M | 325k | 47.95 | |
Pliant Therapeutics (PLRX) | 1.0 | $15M | 783k | 19.33 | |
Prime Medicine (PRME) | 0.9 | $14M | 734k | 18.58 | |
Cytokinetics Com New (CYTK) | 0.9 | $14M | 296k | 45.82 | |
Immuneering Corp Class A Com (IMRX) | 0.7 | $11M | 2.3M | 4.85 | |
Greenlight Biosciencs Hlds P Common Stock | 0.7 | $11M | 9.2M | 1.18 | |
Bridgebio Pharma (BBIO) | 0.7 | $10M | 1.4M | 7.62 | |
Cogent Biosciences (COGT) | 0.7 | $10M | 900k | 11.56 | |
Stoke Therapeutics (STOK) | 0.7 | $10M | 1.1M | 9.23 | |
Arcutis Biotherapeutics (ARQT) | 0.6 | $9.6M | 650k | 14.80 | |
Pharvaris N V (PHVS) | 0.6 | $9.2M | 817k | 11.25 | |
Vigil Neuroscience (VIGL) | 0.5 | $7.7M | 617k | 12.50 | |
Atea Pharmaceuticals (AVIR) | 0.5 | $7.4M | 1.5M | 4.81 | |
Immunovant (IMVT) | 0.5 | $7.1M | 400k | 17.75 | |
Longboard Pharmaceuticals In (LBPH) | 0.5 | $6.9M | 2.1M | 3.26 | |
Alx Oncology Hldgs (ALXO) | 0.5 | $6.9M | 612k | 11.27 | |
Verve Therapeutics (VERV) | 0.5 | $6.8M | 350k | 19.35 | |
Viking Therapeutics (VKTX) | 0.4 | $6.6M | 700k | 9.40 | |
Ideaya Biosciences (IDYA) | 0.4 | $6.4M | 350k | 18.17 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $6.1M | 50k | 122.14 | |
Poseida Therapeutics I (PSTX) | 0.4 | $6.1M | 1.2M | 5.30 | |
Gh Research Ordinary Shares (GHRS) | 0.4 | $5.8M | 593k | 9.72 | |
Adicet Bio (ACET) | 0.4 | $5.4M | 600k | 8.94 | |
Ambrx Biopharma Sponsored Ads | 0.4 | $5.3M | 2.3M | 2.27 | |
Icosavax | 0.3 | $5.1M | 644k | 7.94 | |
Olema Pharmaceuticals (OLMA) | 0.3 | $5.1M | 2.1M | 2.45 | |
Keros Therapeutics (KROS) | 0.3 | $4.8M | 100k | 48.02 | |
Eledon Pharmaceuticals (ELDN) | 0.2 | $2.8M | 1.2M | 2.28 | |
Elevation Oncology (ELEV) | 0.1 | $1.9M | 2.0M | 0.95 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.1 | $1.7M | 562k | 3.10 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $1.6M | 1.6M | 0.99 | |
Galecto (GLTO) | 0.1 | $1.2M | 1.0M | 1.15 | |
Biohaven (BHVN) | 0.1 | $1.1M | 82k | 13.88 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.1 | $922k | 288k | 3.20 | |
Talaris Therapeutics | 0.1 | $919k | 901k | 1.02 | |
Pyxis Oncology Common Stock (PYXS) | 0.1 | $896k | 669k | 1.34 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $745k | 392k | 1.90 | |
Y Mabs Therapeutics (YMAB) | 0.0 | $732k | 150k | 4.88 | |
Graphite Bio | 0.0 | $662k | 200k | 3.32 | |
Harpoon Therapeutics | 0.0 | $392k | 541k | 0.73 | |
Atreca Cl A Com (BCEL) | 0.0 | $255k | 319k | 0.80 | |
Orchard Therapeutics Spon Ads | 0.0 | $95k | 257k | 0.37 |